The Challenge
A clinical-stage biotechnology company was undertaking a network infrastructure refresh, which created a natural opportunity to upgrade from legacy authentication methods to certificate-based access.
Biotech companies routinely handle sensitive research data, including patient records, which means network security needs to meet or exceed regulatory expectations. Passwords come with weaker security that can lead to credential theft and unauthorized access, and are no longer safe for most organizations, especially those in regulated industries. Additionally, operations split between three continents made on-premise hardware impractical, adding an additional challenge for infrastructure management.
With a distributed workforce of almost 300 people and stringent security needs, certificate-based access was the easy choice.
The Solution
An IT consultant recommended SecureW2 solutions to company decision-makers based on previous positive experiences. The company successfully onboarded the JoinNow Platform for over 400 devices, easing the transition by accomplishing the upgrade during the network refresh.
The JoinNow Platform replaced shared passwords with digital certificates tied to individual device identities. The platform manages user and device authentication and access for the company’s multi-continent footprint from a single cloud-hosted deployment, serving multiple locations without the need for on-prem RADIUS servers.
The Results
- 400+ devices enrolled with certificate-based authentication
- Strict regulatory requirements for network security met
- Global coverage across distributed operations from a single cloud deployment